5-amino-1mq (MQ)

Description

Overview

5-Amino-1MQ is a research compound studied for its role in cellular metabolism and NAD⁺ regulation. It acts as an inhibitor of the NNMT enzyme (Nicotinamide N-methyltransferase), which is involved in how cells process nicotinamide and manage energy balance.

This compound is not an approved medication and is intended for research and experimental use only.

Mechanism (high-level)

NNMT influences how much nicotinamide is diverted away from the NAD⁺ salvage pathway.

By inhibiting NNMT, 5-Amino-1MQ is studied for its potential to:

• preserve nicotinamide availability
• support higher intracellular NAD⁺ levels
• shift metabolism toward increased energy expenditure rather than storage

These effects have been demonstrated primarily in animal and cellular studies.

Common Application Scenarios (Research Context)

1️⃣ Metabolic & Energy Regulation Research

Used in studies exploring:

• metabolic efficiency
• fat accumulation pathways
• insulin sensitivity
• energy expenditure signaling

Often investigated in models of obesity and metabolic dysfunction.

2️⃣ NAD⁺ Pathway Studies

5-Amino-1MQ is frequently examined alongside:

• NMN
• NR
• niacin derivatives

In this context, it is used to study how reducing NAD⁺ diversion interacts with NAD⁺ precursor availability.

Typical research question:
Does limiting NNMT activity improve NAD⁺ availability when precursors are present?

3️⃣ Methylation & Cellular Stress Research

Because NNMT consumes methyl groups, its inhibition may affect:

• methylation balance
• SAM / SAH dynamics
• downstream epigenetic signaling

This makes the compound relevant in cellular regulation and stress-response research.

4️⃣ Combination (Stacking) Research

In experimental settings, 5-Amino-1MQ is sometimes evaluated together with:

• NAD⁺ precursors
• methyl-donor support compounds (e.g. betaine/TMG)

These combinations are studied to observe system-level metabolic interactions, not as established therapies.

What Users Should Know

⚠️ Research Status

• No established human clinical trials
• Long-term safety is unknown
• Effects observed in animals may not translate to humans

⚠️ Variability of Effects

Responses reported in experimental contexts vary widely:

• some models show increased energy expenditure
• others show minimal or no effect

Results depend heavily on context, metabolism, and study design.

⚠️ Not Comparable to Appetite-Based Therapies

5-Amino-1MQ:

• does not directly affect appetite hormones
• does not act on GLP-1 or CNS satiety pathways
• targets intracellular metabolic regulation, not hunger signaling

Summary

5-Amino-1MQ is a metabolic research compound used to study NNMT inhibition, NAD⁺ regulation, and energy balance. It is most commonly explored in metabolic, obesity, and cellular metabolism research, often alongside NAD⁺-related compounds.

It remains experimental, with promising mechanistic logic but limited real-world validation.